Overcoming steroid unresponsiveness in airways disease

Biochemical Society Transactions

Volumn 37, Issue 4, 2009, Pages 824-829

  Adcock, Ian M ^a,b   Chou, Pai Chien ^a,b   Durham, Andrew ^a,b   Ford, Paul ^a,b  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

Author keywords

Asthma; Chronic obstructive pulmonary disease (COPD); Corticosteroid; Mitogen activated protein kinase (MAPK); Steroid; Theophylline

Indexed keywords

CORTICOSTEROID; CURCUMIN; GLUCOCORTICOID; HISTONE DEACETYLASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; NITRIC OXIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; RESVERATROL; ROSIGLITAZONE; STEROID; STRESS ACTIVATED PROTEIN KINASE; THEOPHYLLINE; TRANSCRIPTION FACTOR AP 1; GLUCOCORTICOID RECEPTOR;

ANTIGEN PRESENTING CELL; ANTIINFLAMMATORY ACTIVITY; ASTHMA; BINDING AFFINITY; CD4+ T LYMPHOCYTE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CONFERENCE PAPER; DNA BINDING; DRUG EFFICACY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENE REPRESSION; GENE TRANSLOCATION; HUMAN; LIGAND BINDING; LUNG FUNCTION; LUNG LAVAGE; LYMPHOCYTE ACTIVATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY TRACT DISEASE; SIGNAL TRANSDUCTION; TREATMENT FAILURE; TREATMENT RESPONSE; VIRUS INFECTION; ANIMAL; BIOLOGICAL MODEL; DRUG EFFECT; METABOLISM; REVIEW;

ADRENAL CORTEX HORMONES; ANIMALS; ASTHMA; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION;

EID: 70349325405     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0370824     Document Type: Conference Paper

References (50)

1. Masoli, M., Fabian, D., Holt, S. and Beasley, R. (2004) The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 59, 469-478
2. Wenzel, S.E. and Busse, W.W. (2007) Severe asthma: lessons from the Severe Asthma Research Program. J. Allergy Clin. Immunol. 119, 14-21
3. Wenzel, S.E., Barnes, P.J., Bleecker, E.R., Bousquet, J., Busse, W., Dahlen, S.E., Holgate, S.T., Meyers, D.A., Rabe, K.F. and Antczak, A. (2009) A randomized, double-blind, placebo-controlled study of tumor necrosis factor-α blockade in severe persistent asthma. Am. J. Respir. Crit. Care Med. 179, 549-558
4. Haldar, P., Brightling, C.E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., Marshall, R.P., Bradding, P., Green, R.H., Wardlaw, A.J. and Pavord, I.D. (2009) Mepolizumab and exacerbations of refractory eosinophilic asthma. N. Engl. J. Med. 360, 973-984
5. Nair, P., Pizzichini, M.M., Kjarsgaard, M., Inman, M.D., Efthimiadis, A., Pizzichini, E., Hargreave, F.E. and O'Byrne, P.M. (2009) Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N. Engl. J. Med. 360, 985-993
6. Barnes, P.J. (2004) New drugs for asthma. Nat. Rev. Drug Discov. 3, 831-844
7. De Bosscher, K., Van, C.K., Meijer, O.C. and Haegeman, G. (2008) Selective transrepression versus transactivation mechanisms by glucocorticoid receptor modulators in stress and immune systems. Eur. J. Pharmacol. 583, 290-302
8. Moore, W.C., Bleecker, E.R., Curran-Everett, D., Erzurum, S.C., Ameredes, B.T., Bacharier, L., Calhoun, W.J., Castro, M., Chung, K.F. and Clark, M.P. (2007) Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J. Allergy Clin. Immunol. 119, 405-413
9. Adcock, I.M., Ford, P.A., Bhavsar, P., Ahmad, T. and Chung, K.F. (2008) Steroid resistance in asthma: mechanisms and treatment options. Curr. Allergy Asthma Rep. 8, 171-178
10. Adcock, I.M., Caramori, G. and Chung, K.F. (2008) New targets for drug development in asthma. Lancet 372, 1073-1087
11. Cohen, L., E, X., Tarsi, J., Ramkumar, T., Horiuchi, T.K., Cochran, R., DeMartino, S., Schechtman, K.B., Hussain, I., Holtzman, M.J. and Castro, M. (2007) Epithelial cell proliferation contributes to airway remodeling in severe asthma. Am. J. Respir. Crit. Care Med. 176, 138-145
12. Irusen, E., Matthews, J.G., Takahashi, A., Barnes, P.J., Chung, K.F. and Adcock, I.M. (2002) p38 mitogen-activated protein kinase-induced glucocorticoid receptor phosphorylation reduces its activity: role in steroid-insensitive asthma. J. Allergy Clin. Immunol. 109, 649-657
13. Matthews, J.G., Ito, K., Barnes, P.J. and Adcock, I.M. (2004) Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patients. J. Allergy Clin. Immunol. 113, 1100-1108
14. Bhavsar, P., Hew, M., Khorasani, N., Torrego, A., Barnes, P.J., Adcock, I.M. and Chung, K.F. (2008) Relative corticosteroid insensitivity of alveolar macrophages in severe asthma compared to non-severe asthma. Thorax 63, 784-790
15. Adcock, I.M. and Barnes, P.J. (2008) Molecular mechanisms of corticosteroid resistance. Chest 134, 394-401
16. Roth, M., Johnson, P.R., Borger, P., Bihl, M.P., Rudiger, J.J., King, G.G., Ge, Q., Hostettler, K., Burgess, J.K., Black, J.L. and Tamm, M. (2004) Dysfunctional interaction of C/EBPα and the glucocorticoid receptor in asthmatic bronchial smooth-muscle cells. N. Engl. J. Med. 351, 560-574
17. Hakonarson, H., Bjornsdottir, U.S., Halapi, E., Bradfield, J., Zink, F., Mouy, M., Helgadottir, H., Gudmundsdottir, A.S., Andrason, H. and Adalsteinsdottir, A.E. (2005) Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients. Proc. Natl. Acad. Sci. U.S.A. 102, 14789-14794
18. Leung, D.Y. and Bloom, J.W. (2003) Update on glucocorticoid action and resistance. J. Allergy Clin. Immunol. 111, 3-22
19. Goleva, E., Li, L.B., Eves, P.T., Strand, M.J., Martin, R.J. and Leung, D.Y. (2006) Increased glucocorticoid receptor β alters steroid response in glucocorticoid-insensitive asthma. Am. J. Respir. Crit. Care Med. 173, 607-616
20. Lewis-Tuffin, L.J., Jewell, C.M., Bienstock, R.J., Collins, J.B. and Cidlowski, J.A. (2007) Human glucocorticoid receptor β binds RU-486 and is transcriptionally active. Mol. Cell. Biol. 27, 2266-2282
21. Liu, W., Liang, Q., Balzar, S., Wenzel, S., Gorska, M. and Alam, R. (2008) Cell-specific activation profile of extracellular signal-regulated kinase 1/2, Jun N-terminal kinase, and p38 mitogen-activated protein kinases in asthmatic airways. J. Allergy Clin. Immunol. 121, 893-902
22. Goleva, E., Li, L.B. and Leung, D.Y. (2009) IFN-γ reverses IL-2- and IL-4-mediated T-cell steroid resistance. Am. J. Respir. Cell Mol. Biol. 40, 223-230
23. Clark, A.R., Martins, J.R. and Tchen, C.R. (2008) Role of dual specificity phosphatases in biological responses to glucocorticoids. J. Biol. Chem. 283, 25765-25769
24. Loke, T.K., Mallett, K.H., Ratoff, J., O'Connor, B.J., Ying, S., Meng, Q., Soh, C., Lee, T.H. and Corrigan, C.J. (2006) Systemic glucocorticoid reduces bronchial mucosal activation of activator protein 1 components in glucocorticoid-sensitive but not glucocorticoid-resistant asthmatic patients. J. Allergy Clin. Immunol. 118, 368-375
25. Hew, M., Bhavsar, P., Torrego, A., Meah, S., Khorasani, N., Barnes, P.J., Adcock, I. and Chung, K.F. (2006) Relative corticosteroid insensitivity of peripheral blood mononuclear cells in severe asthma. Am. J. Respir. Crit. Care Med. 174, 134-141
26. Bilodeau, S., Vallette-Kasic, S., Gauthier, Y., Figarella-Branger, D., Brue, T., Berthelet, F., Lacroix, A., Batista, D., Stratakis, C. and Hanson, J. (2006) Role of Brg1 and HDAC2 in GR trans-repression of the pituitary POMC gene and misexpression in Cushing disease. Genes Dev. 20, 2871-2886
27. Panickar, J., Lakhanpaul, M., Lambert, P.C., Kenia, P., Stephenson, T., Smyth, A. and Grigg, J. (2009) Oral prednisolone for preschool children with acute virus-induced wheezing. N. Engl. J. Med. 360, 329-338
28. Ducharme, F.M., Lemire, C., Noya, F.J., Davis, G.M., Alos, N., Leblond, H., Savdie, C., Collet, J.P., Khomenko, L., Rivard, G. and Platt, R.W. (2009) Preemptive use of high-dose fluticasone for virus-induced wheezing in young children. N. Engl. J. Med. 360, 339-353
29. Bellattato, C., Adcock, I.M., Ito, K., Caramori, G., Casolari, P., Ciaccia, A., Barnes, P.J., Johnston, S.L. and Papi, A. (2003) Rhinovirus infection reduces glucocorticoid receptor nuclear translocation in airway epithelial cells. Eur. Respir. J. 22, (Suppl.), 565S
30. Chaudhuri, R., Livingston, E., McMahon, A.D., Lafferty, J., Fraser, I., Spears, M., McSharry, C.P. and Thomson, N.C. (2006) Effects of smoking cessation on lung function and airway inflammation in smokers with asthma. Am. J. Respir. Crit. Care Med. 174, 127-133
31. Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R.K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M.G. and Glass, C.K. (2005) Molecular determinants of crosstalk between nuclear receptors and Toll-like receptors. Cell 122, 707-721
32. Farrow, S.N. (2008) Nuclear receptors: doubling up in the lung. Curr. Opin. Pharmacol. 8, 275-279
33. Spears, M., Donnelly, I., Jolly, L., Brannigan, M., Ito, K., McSharry, C., Lafferty, J., Chaudhuri, R., Braganza, G. and Bareille, P. (2009) Bronchodilatory effect of the PPAR-γ agonist rosiglitazone in smokers with asthma. Clin. Pharmacol. Ther. 86, 49-53
34. Barnes, P.J. (2007) Chronic obstructive pulmonary disease: a growing but neglected global epidemic. PLoS Med. 4, e112
35. Rahman, I. and Adcock, I.M. (2006) Oxidative stress and redox regulation of lung inflammation in COPD. Eur. Respir. J. 28, 219-242
36. Singh, D., Richards, D., Knowles, R.G., Schwartz, S., Woodcock, A., Langley, S. and O'Connor, B.J. (2007) Selective inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am. J. Respir. Crit. Care Med. 176, 988-993
37. Kent, L.M., Smyth, L.J., Plumb, J., Clayton, C.L., Fox, S.M., Ray, D.W., Farrow, S.N. and Singh, D. (2009) Inhibition of lipopolysaccharidestimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4- (4-fluoro-2-methylphenyl)-7-oxo-7,8- dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504). J. Pharmacol. Exp. Ther. 328, 458-468
38. Culpitt, S.V., Rogers, D.F., Fenwick, P.S., Shah, P., De Matos, C., Russell, R.E., Barnes, P.J. and Donnelly, L.E. (2003) Inhibition by red wine extract, resveratrol, of cytokine release by alveolar macrophages in COPD. Thorax 58, 942-946
39. Meja, K.K., Rajendrasozhan, S., Adenuga, D., Biswas, S.K., Sundar, I.K., Spooner, G., Marwick, J.A., Chakravarty, P., Fletcher, D. and Whittaker, P. (2008) Curcumin restores corticosteroid function in monocytes exposed to oxidants by maintaining HDAC2. Am. J. Respir. Cell Mol. Biol. 39, 312-323
40. Ito, K., Yamamura, S., Essilfie-Quaye, S., Cosio, B., Ito, M., Barnes, P.J. and Adcock, I.M. (2006) Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression. J. Exp. Med. 203, 7-13
41. Ito, K., Ito, M., Elliott, W.M., Cosio, B., Caramori, G., Kon, O.M., Barczyk, A., Hayashi, S., Adcock, I.M., Hogg, J.C. and Barnes, P.J. (2005) Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N. Engl. J. Med. 352, 1967-1976
42. Barnes, P.J. (2007) New molecular targets for the treatment of neutrophilic diseases. J. Allergy Clin. Immunol. 119, 1055-1062
43. Barnes, P.J. (2003) Theophylline: new perspectives for an old drug. Am. J. Respir. Crit. Care Med. 167, 813-818
44. Marwick, J.A., Wallis, G., Meja, K., Kuster, B., Bouwmeester, T., Chakravarty, P., Fletcher, D., Whittaker, P.A., Barnes, P.J. and Ito, K. (2008) Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem. Biophys. Res. Commun. 377, 797-802
45. Fox, J.C. and Fitzgerald, M.F. (2009) The role of animal models in the pharmacological evaluation of emerging anti-inflammatory agents for the treatment of COPD. Curr. Opin. Pharmacol. 9, 231-242
46. Cosio, B.G., Iglesias, A., Rios, A., Noguera, A., Sala, E., Ito, K., Barnes, P.J. and Agusti, A. (2009) Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of chronic obstructive pulmonary disease. Thorax 64, 424-429
47. Ford, P.A., Durham, A.L., Russell, R.E., Adcock, I.M. and Barnes, P.J. (2008) A clinical trial demonstrating that low dose theophylline attenuates steroid insensitivity in COPD. Am. J. Respir. Crit. Care Med. 177, A651
48. Spears, M., Donnelly, I., Jolly, L., Brannigan, M., Ito, K., McSharry, C., Lafferty, J., Chaudhuri, R., Braganza, G. and Adcock, I.M. (2009) Effect of theophylline plus beclometasone on lung function in smokers with asthma: a pilot study. Eur. Respir. J. 33, 1010-1017
49. Marwick, J.A., Caramori, G., Stevenson, C.S., Casolari, P., Jazrawi, E., Barnes, P.J., Ito, K., Adcock, I.M., Kirkham, P.A. and Papi, A. (2009) Inhibition of PI3Kα restores glucocorticoid function in smoking-induced airway inflammation in mice. Am. J. Respir. Crit. Care Med. 179, 542-548
50. Marwick, J.A., Ito, K., Adcock, I.M. and Kirkham, P.A. (2007) Oxidative stress and steroid resistance in asthma and COPD: pharmacological manipulation of HDAC2 as a therapeutic strategy. Expert Opin. Ther. Targets 11, 745-755